Skip to main content
Log in

Effect modelling for drugs undergoing enterohepatic circulation

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

A multi-compartment pharmacokinetic model with enterohepatic circulation, was used in simulations and in a clinical trial with morphine. A hypothetical effect compartment was linked to either the central or the peripheral disposition compartment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dahlström B.E., Paalzow L.K. (1978): Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J. Pharmacokinet. Biopharm., 6, 505–519.

    Article  PubMed  Google Scholar 

  2. Colburn W.A. (1984): Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile. J. Pharm. Sci., 73, 313–317.

    Article  PubMed  CAS  Google Scholar 

  3. Harrison L.I., Gibaldi M. (1976): Influence of cholestasis on drug elimination: pharmacokinetics. J. Pharm. Sci., 65, 1346–1348.

    Article  PubMed  CAS  Google Scholar 

  4. Steimer J.-L., Plusquellec Y., Guillaume A., Boisvieux J.-F. (1982): A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation. J. Pharm. Sci., 71, 297–302.

    Article  PubMed  CAS  Google Scholar 

  5. Veng Pedersen P., Miller R. (1980): Pharmacokinetics of doxycycline reabsorption. J. Pharm. Sci. 69, 204–207.

    Article  Google Scholar 

  6. Shepard TA., Reuning R.H., Aarons L.J. (1985): Estimation of area under the curve for drugs subject to enterohepatic cycling. J. Pharmacokinet. Biopharm., 13, 589–608.

    Article  PubMed  CAS  Google Scholar 

  7. Labat C., Mansour K., Malmary MF., Terrissol M., Oustrin J. (1987): A variable reabsorption time-delay model for pharmacokinetics of drugs. Eur. J. Drug Metab. Pharmacokinet., 12, 129–133.

    Article  PubMed  CAS  Google Scholar 

  8. Holford NHG, Sheiner L.B. (1981): Understanding the dose-effect relationship: clinical application of the pharmacokinetic-pharmacodynamic models. Clin. Pharmacokinet. 6, 429–453.

    Article  PubMed  CAS  Google Scholar 

  9. Colburn W.A. (1981): Simultaneous pharmacokinetic and pharmacodynamic modeling. J. Pharmacokinet. Biopharm., 9, 367–388.

    Article  PubMed  CAS  Google Scholar 

  10. Benet L.Z., Turi JS. (1971): Use of general partial fraction theorem for obtaining inverse Laplace transforms in pharmacokinetic analysis. J. Pharm. Sci., 60, 1593–1594.

    Article  PubMed  CAS  Google Scholar 

  11. Haborak G.E., Benmaman J.D., Warren. Jr W. (1979): Mathematical treatment of linear mammillary models using inverse Laplace transforms. J. Pharm. Sci. 68, 932–933.

    Article  PubMed  CAS  Google Scholar 

  12. Shepard T.A., Reuning R.H., Aarons L.J. (1985): Estimation of area under the curve for drugs subject to enterohepatic cycling. J. Pharmacokinet. Biopharm., 13, 589–608.

    Article  PubMed  CAS  Google Scholar 

  13. Westerling D., Frigeren L., Höglund P. Morphine pharmacokinetics and effects on salivation and continuous reaction times. Manuscript, submitted for publication.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Höglund, P., Ohlin, M. Effect modelling for drugs undergoing enterohepatic circulation. European Journal of Drug Metabolism and Pharmacokinetics 18, 333–338 (1993). https://doi.org/10.1007/BF03190182

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190182

Keywords

Navigation